Type 1 Diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric Cancer: A Case Report

Nivolumab, a fully human IgG4 immune checkpoint inhibitor (ICI) antibody, has been approved for a variety of cancers. Several endocrine-associated immune-related adverse events have been reported, but the incidence rate is relatively low. This is a case of a patient with gastric cancer who underwent...

Descripción completa

Detalles Bibliográficos
Autores principales: Marshall, Shoko, Kizuki, Aki, Kitaoji, Tadashi, Imada, Hiroshi, Kato, Hayato, Hosoda, Mana, Ishikawa, Motonao, Sakura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590777/
https://www.ncbi.nlm.nih.gov/pubmed/33173483
http://dx.doi.org/10.1159/000510044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590777/
https://www.ncbi.nlm.nih.gov/pubmed/33173483
http://dx.doi.org/10.1159/000510044

Ejemplares similares